CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results

Go back to CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results
(NASDAQ: CRSP) Delayed: 58.33 --0 (-0%)
Previous Close $58.33    52 Week High $18.88 
Open $58.33    52 Week Low $13.75 
Day High $58.33    P/E N/A 
Day Low $58.33    EPS $0.00 
Volume 4,066